Our goal was to report our institutional experience with recombinant factor VIIa for the treatment and/or prevention of bleeding in nonhemophiliac children.
The aim of this study was to investigate the impact of the duration of low oxygen delivery (<272 mL. min−1.m−2), during cardiopulmonary bypass on kidney function.
